Biocon declares positive results for phase I comparative study on Biosimilar Insulin Glargine
Study was conducted in type I diabetes Mellitus patients, which met all its primary and secondary endpoints
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.